Long-Term Survival With CML With Imatinib or Transplantation as First-Line Treatment: Comparison of Outcomes From CML Studies IIIA and IV

Cellular Therapy and Transplantation - Germany
doi 10.18620/ctt-1866-8836-2017-6-4-13-20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Foundation for the Development of Bone Marrow Transplantation

Related search

CML: Langzeitresultate Zum Imatinib-Stopp

Im Focus Onkologie
2017English

Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis

Bone Marrow Transplantation
TransplantationHematology
2011English

CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Duplication of Isoderivative Ph Chromosome With Tp53 Deletion in a Case of Imatinib Resistant CML

International Journal of Human Genetics
Genetics
2019English

Downregulation of Γ-Catenin Inhibits CML Cell Growth and Potentiates the Response of CML Cells to Imatinib Through Β-Catenin Inhibition

International Journal of Molecular Medicine
MedicineGenetics
2012English

P3.13-10 Factors Associated With Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Comparison of Total Body Irradiation vs Busulfan in Combination With Cyclophosphamide as Conditioning for Unrelated Stem Cell Transplantation in CML Patients

Bone Marrow Transplantation
TransplantationHematology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy